KATHRYN B ALGUIRE M.D. NPI 1568468882

NPI Details

Kathryn B Alguire, M.D. is a medical oncology internal medicine in Norton Shores, MI with 27 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Kathryn B Alguire, M.D. NPI is 1568468882. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MICHIGAN STATE UNIVERSITY COLLEGE OF HUMAN MEDICINE
Graduation Year:1999

The provider's business location address is:

6425 S HARVEY ST
SUITE 200
NORTON SHORES, MI
ZIP 49444-739
Phone: (231) 737-3469
Fax: (231) 737-4548

The NPI 1568468882 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Ferritin (blood protein) level (HCPCS:82728)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Magnesium level (HCPCS:83735)
• Blood creatinine level (HCPCS:82565)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Protein measurement, serum (HCPCS:84165)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Vitamin d-3 level (HCPCS:82306)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Folic acid level, serum (HCPCS:82746)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Declotting of central venous tube (HCPCS:36593)

The enumeration date for this NPI number is 6/22/2005 and was last updated on 3/13/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: